Previous 10 | Next 10 |
Whether you’re looking for a Santa Claus Rally or trying to find some tax-loss harvesting opportunities, omicron fears have slapped the market in the face to start the short holiday week. Over the weekend, concerns began to grow thanks to commentary from the scientific community. The...
Concentric by Ginkgo and XpresCheck™ Confirm First North American Detections of Novel BA.3 Sublineage of Omicron Variant through CDC COVID-19 Air Travel Biosecurity Program PR Newswire BOSTON , Dec. 18, 2021 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) toda...
NEW YORK, Dec. 16, 2021 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced the opening of Treat™’s first brick and mortar location in Terminal 4 at John F. Kennedy In...
XpresSpa has pivoted its business from an airport spa business to an airport Covid testing business. XpresSpa has 99 cents a share in net balance sheet cash. It earned roughly 5 cents a share in the third quarter driven largely by Covid testing at airports. It is expanding thi...
Shares of XpresSpa (XSPA +6.5%) are up 7% after the company said that a collaboration with Ginkgo Bioworks (DNA +1.6%) was able to detect the Omicron variant of COVID-19 in tests from international passengers at Newark International Airport. Ginkgo collected, identified, and sequenc...
Concentric by Ginkgo Confirms Detection of Omicron Variant through COVID-19 Air Travel Biosecurity Collaboration with CDC and XpresCheck PR Newswire BOSTON , Dec. 7, 2021 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today confirmed that it has collected, identifie...
NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), a health and wellness company, today announced that the Company will participate in the Water Tower Research Fireside Chat Series on Tuesday, December 7...
Celyad Oncology (NASDAQ:CYAD) +31% raises $32.5M in private placement with Fortress Investment Group. Longeveron (NASDAQ:LGVN) +26% on FDA orphan designation to Lomecel-B Marvell Technology (NASDAQ:MRVL) +22% after third-quarter earnings beat Code Chain New Continent ...
If you’re looking for the next round of penny stocks to buy right now, you’ve landed in the right place. Today we’re looking at three stocks that can be purchased for less than $4 right now. Whether they’re worth the risk or not is something I’ll leave up ...
XpresSpa Group (XSPA -0.6%), with Ginkgo Bioworks (DNA -0.2%) and the CDC, will expand an airport COVID-19 surveillance program to include the new Omicron variant. XpresSpa's XpresCheck subsidiary expanded its COVID-19 biosurveillance program on Sunday to test passengers entering the Uni...
News, Short Squeeze, Breakout and More Instantly...
XpresSpa Group Inc. Company Name:
XSPA Stock Symbol:
NASDAQ Market:
NEW YORK, Oct. 24, 2022 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), formerly XpresSpa Group, Inc. (Nasdaq: XSPA), today announced a corporate rebranding of the Company to XWELL. XWELL unveiled a new visual identity and website , in connection with the rebr...
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) -- XpresSpa Group, Inc. (Nasdaq: XSPA) ("XpresSpa" or the "Company"), a leader in health and wellness solutions for people on the go, has launched the Women’s Health Initiative as part of its overarching social responsibility platform strateg...
XpresCheck, through its Partnership with Ginkgo Bioworks, Awarded New CDC Biosurveillance Contract Valued Up To $61 Million Leading Health and Wellness Provider for ‘People on the Go’ Demonstrated Success Executing Agai...